| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,245 |
5,898 |
$533K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,072 |
5,466 |
$516K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,347 |
4,390 |
$496K |
| 80053 |
Comprehensive metabolic panel |
8,348 |
6,159 |
$217K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,323 |
1,072 |
$207K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
551 |
485 |
$205K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,539 |
2,411 |
$161K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,882 |
2,793 |
$106K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
520 |
442 |
$104K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,427 |
1,313 |
$75K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,654 |
1,301 |
$75K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
937 |
797 |
$72K |
| S0028 |
Injection, famotidine, 20 mg |
332 |
284 |
$32K |
| 81001 |
|
4,571 |
3,862 |
$22K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
712 |
590 |
$21K |
| G0378 |
Hospital observation service, per hour |
2,209 |
860 |
$19K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
565 |
331 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
455 |
358 |
$16K |
| 71045 |
Radiologic examination, chest; single view |
4,729 |
3,869 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,172 |
3,881 |
$14K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
652 |
535 |
$14K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
684 |
399 |
$13K |
| A9270 |
Non-covered item or service |
1,979 |
1,042 |
$12K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,879 |
1,681 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,453 |
6,826 |
$12K |
| 87070 |
|
842 |
756 |
$12K |
| 84703 |
|
3,466 |
3,040 |
$12K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
912 |
732 |
$11K |
| 85027 |
|
3,356 |
2,525 |
$11K |
| 85610 |
|
1,736 |
1,259 |
$9K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,426 |
4,312 |
$9K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,334 |
3,986 |
$9K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
347 |
80 |
$8K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
15 |
13 |
$8K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
15 |
14 |
$8K |
| 84484 |
|
3,219 |
1,963 |
$7K |
| 82962 |
|
1,789 |
687 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,182 |
633 |
$6K |
| J3490 |
Unclassified drugs |
106 |
38 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
792 |
583 |
$5K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
748 |
533 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,031 |
2,964 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
558 |
265 |
$5K |
| 80076 |
|
209 |
181 |
$4K |
| 85730 |
|
1,225 |
921 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,508 |
894 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,306 |
2,560 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
365 |
281 |
$3K |
| 83880 |
|
503 |
410 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
105 |
71 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
295 |
244 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,018 |
1,716 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
345 |
164 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
39 |
37 |
$2K |
| 82550 |
|
1,802 |
1,310 |
$2K |
| 85379 |
|
406 |
358 |
$2K |
| 83690 |
|
2,410 |
2,031 |
$1K |
| 96376 |
|
919 |
531 |
$1K |
| 87430 |
|
763 |
707 |
$847.67 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,108 |
1,797 |
$815.90 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
419 |
329 |
$796.22 |
| 83735 |
|
1,061 |
804 |
$699.71 |
| 87040 |
|
289 |
141 |
$634.54 |
| 82374 |
|
297 |
247 |
$620.56 |
| 93307 |
|
19 |
14 |
$617.54 |
| 84443 |
Thyroid stimulating hormone (TSH) |
412 |
331 |
$591.62 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,520 |
1,149 |
$492.85 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
123 |
72 |
$475.28 |
| C1769 |
Guide wire |
154 |
92 |
$475.28 |
| 82565 |
|
366 |
300 |
$379.76 |
| 71046 |
Radiologic examination, chest; 2 views |
99 |
79 |
$349.08 |
| 84295 |
|
287 |
236 |
$293.20 |
| 84520 |
|
350 |
293 |
$293.20 |
| 82947 |
|
296 |
245 |
$293.20 |
| 82435 |
|
287 |
238 |
$293.20 |
| 84132 |
|
322 |
262 |
$293.20 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
28 |
24 |
$276.75 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
344 |
268 |
$210.71 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
166 |
147 |
$205.56 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
17 |
15 |
$196.27 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
938 |
333 |
$192.89 |
| 93976 |
|
44 |
41 |
$173.28 |
| 87088 |
|
170 |
141 |
$132.19 |
| 93970 |
|
15 |
13 |
$130.85 |
| 86850 |
|
190 |
150 |
$114.42 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
32 |
24 |
$89.96 |
| 86900 |
|
192 |
150 |
$83.16 |
| 99001 |
|
221 |
201 |
$75.73 |
| 86901 |
|
192 |
150 |
$54.15 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
45 |
37 |
$43.48 |
| 87186 |
|
204 |
157 |
$21.21 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
182 |
160 |
$20.41 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
79 |
65 |
$12.47 |
| 87210 |
|
45 |
42 |
$5.22 |
| 74022 |
|
42 |
39 |
$4.52 |
| 84100 |
|
86 |
68 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
112 |
83 |
$0.00 |
| 87076 |
|
80 |
59 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
48 |
38 |
$0.00 |
| 84702 |
|
94 |
75 |
$0.00 |
| 99152 |
|
20 |
12 |
$0.00 |
| 87077 |
|
15 |
12 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
131 |
88 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
70 |
41 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
16 |
12 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
32 |
28 |
$0.00 |
| 83605 |
|
113 |
84 |
$0.00 |
| 93971 |
|
41 |
37 |
$0.00 |
| 82607 |
|
43 |
36 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
36 |
24 |
$0.00 |
| 82746 |
|
14 |
12 |
$0.00 |